Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 4Sarcoma 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Kidney Neoplasms 7Carcinoma, Renal Cell 7Breast Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Myeloproliferative Disorders 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphocytic, Chronic, B-Cell 6Hodgkin Disease 6Congenital Abnormalities 6Burkitt Lymphoma 6Testicular Neoplasms 5Sezary Syndrome 5Primary Myelofibrosis 5Pdgfra-Associated Chronic Eosinophilic Leukemia 5Mycosis Fungoides 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Neutrophilic, Chronic 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Myeloid, Acute 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Hairy Cell 5

Interventions

Docetaxel 292Prednisone 241enzalutamide 195Leuprolide 185Radiotherapy 179Abiraterone Acetate 170Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 93abiraterone 83gallium 68 PSMA-11 81Specimen Handling 73darolutamide 67Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 53Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Flow Cytometry × Genitourinary × Clear all
NCT00779168 2022-03-31

White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy

City of Hope Medical Center

Phase 1 Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

NCT02450435 2015-12-30

The Detection of Circulating Tumor Cells (CTCs) in Patients With Prostatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Fuda Cancer Hospital, Guangzhou

Completed
60 enrolled
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT00379119 2012-10-11

Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer

University of California, San Francisco

Terminated
20 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡